LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Начало・Списък с акции・NeoGenomics Inc

NeoGenomics Inc

Затворен

10.01 0.4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

9.78

Максимум

10.16

Ключови измерители
By Trading Economics
Приходи	18M -27M
Продажби	6.5M 188M
EPS	0.03
Марж на печалбата	-14.446
Служители	2,200
EBITDA	44M -3.5M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+32.9% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	33M 1.3B
Предишно отваряне	9.61
Предишно затваряне	10.01

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

7.7 / 10.27 Подкрепа & съпротива

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.11.2025 г., 19:28 ч. UTC

Значими двигатели на пазара

Robinhood Shares Slide After Cash Delivery Service Rollout

6.11.2025 г., 22:19 ч. UTC

Печалби

Значими двигатели на пазара

Block Shares Slide After 3Q Results Miss Estimates

3.11.2025 г., 15:21 ч. UTC

Значими двигатели на пазара

Tharimmune Shares Rise After $540 Million Private Placement

31.10.2025 г., 16:47 ч. UTC

Печалби

Значими двигатели на пазара

Strategy Shares Gain After 3Q Results, Fiscal Year Outlook Top Estimates

13.11.2025 г., 21:23 ч. UTC

Печалби

Intchains Group 3Q Rev $1.3M >ICG

13.11.2025 г., 12:08 ч. UTC

Придобивния, сливания и поглъщания

Intchains Group to Acquire a Proof-of-Stake Technology Platform, and Expand Blockchain Infrastructure Capabilities

13.11.2025 г., 09:29 ч. UTC

Пазарно говорене

Stablecoin Growth Expected by Treasury Secretary Could Have Big Implications -- Market Talk

13.11.2025 г., 08:23 ч. UTC

Пазарно говорене

Bitcoin Edges Higher as U.S. Government Shutdown Ends -- Market Talk

12.11.2025 г., 08:09 ч. UTC

Пазарно говорене

Bitcoin Edges Higher on U.S. Government Reopening Hopes -- Market Talk

12.11.2025 г., 08:09 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

11.11.2025 г., 08:53 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

11.11.2025 г., 08:53 ч. UTC

Пазарно говорене

Bitcoin Eases on Renewed U.S.-China Trade Concerns -- Market Talk

10.11.2025 г., 08:05 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

10.11.2025 г., 08:05 ч. UTC

Пазарно говорене

Bitcoin Rises on Hopes For End to U.S. Government Shutdown -- Market Talk

7.11.2025 г., 13:02 ч. UTC

Пазарно говорене

Bitcoin Falls Back Below $100,000 on Risk Aversion -- Market Talk

7.11.2025 г., 08:12 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

7.11.2025 г., 08:12 ч. UTC

Пазарно говорене

Bitcoin Struggles For Meaningful Recovery in Wake of Selloff -- Market Talk

6.11.2025 г., 08:29 ч. UTC

Пазарно говорене

Bitcoin Stabilizes as Risk Appetite Improves -- Market Talk

5.11.2025 г., 19:54 ч. UTC

Придобивния, сливания и поглъщания

Let's Call Him 'Warn' Buffett. Berkshire's Recent Moves Suggest It's Time to Play Defense. -- Barrons.com

5.11.2025 г., 07:56 ч. UTC

Пазарно говорене

Bitcoin Recovers Slightly After Falling Below $100,000 -- Market Talk

4.11.2025 г., 21:57 ч. UTC

Пазарно говорене

Canada Budget: 'Tamer' Than Expected After Promise of Bold Bets -- Market Talk

4.11.2025 г., 14:58 ч. UTC

Пазарно говорене

Bitcoin Extends Losses on U.S. Rate-Cut Doubts -- Market Talk

4.11.2025 г., 08:00 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.11.2025 г., 08:00 ч. UTC

Пазарно говорене

Bitcoin Falls on Reduced U.S. Rate Cut Bets, Balancer Hack -- Market Talk

3.11.2025 г., 15:06 ч. UTC

Значими двигатели на пазара

Tharimmune Shares Rise After $540M Private Placement

3.11.2025 г., 14:36 ч. UTC

Пазарно говорене

Bitcoin Could Recover After October Decline -- Market Talk

3.11.2025 г., 08:17 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

3.11.2025 г., 08:17 ч. UTC

Пазарно говорене

Bitcoin Falls as U.S. Rate-Cut Doubts Dent Sentiment -- Market Talk

31.10.2025 г., 16:32 ч. UTC

Печалби

Значими двигатели на пазара

Strategy Shares Gain After 3Q Results, FY Outlook Top Estimates

31.10.2025 г., 13:13 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Apple, Amazon, Netflix, Nvidia, Western Digital, Strategy, Coinbase, Exxon, and More -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

32.9% нагоре

12-месечна прогноза

Среден 13.29 USD 32.9%

Висок 17 USD

Нисък 11 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на NeoGenomics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

7.7 / 10.27Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.